Jounce Therapeutics, Inc.
Anti-ICOS Antibodies for the Treatment of Cancer
Last updated:
Abstract:
Methods of treating cancer with multiple doses of anti-ICOS antibodies and multiple doses of anti-CTLA4 antibodies are provided.
Status:
Application
Type:
Utility
Filling date:
10 Mar 2020
Issue date:
5 May 2022